2023. Risk Analysis of AST and ALT level in Patients with Diabetes Mellitus Type 2. Jaringan Laboratorium Medis. 4, 1 (Dec. 2023), 51–55. DOI:https://doi.org/10.31983/jlm.v4i1.8489.